Læknaneminn - 01.10.1995, Síða 14

BEINMERGSFLUTNINGAR
HEIMILDIR.
1. Gatti RA, Meuwissen JJ, Allen HD, Hong R, Good RA.
Immunological reconstitution of sex-linked lymphopenic
immunological deficiency. Lancet 1968; i: 1366-69.
2. De Koning J, Dooren LJ, Van Berkkum DW, Van Rood JJ, Dicke
Ka, Radl J. Transplantation of bone marrow cell and fetal thymus
in an infant with lymphopenic imunological deficiency. Lancet
1969;i: 1223-26.
3. Bach FH, Albertini RJ, Anderson JL, Joo P, Bortin M. Bone
marrow transplantation in a patient with the Wiskott Aldrich
syndrome. Lancet 1968;ii: 1364-66.
4. Vossen JM. Bone marrow transplantation in Children. Bailliere's
clinical paediatrics 1993; 1029-1059.
5. Gratwohl A, Hermans J. Bone marrow transplantation activity in
Europe 1992. Report from the European Group for Bone Marrow
Transplantation (EBMT): Bone Marrow Transplantl994(l):5:5-
10.
6. Fischer A, Landais P, Friedrich W et al. European experience of
bone marrow transplantation for severe combined
immunodeficiency. Lancet 1990; 336:850.
7. Bacigalupo A, Hows J, Gluckman E et al. Bone marrow
transplantation versus immunosuppression for the treatment of
severe aplastic anaemia: a report of the EBMT SAA Working
Party. Br.J. Haematol 1988; 70:177.
8. Report for the Working Party on Leukaemia. European Group for
Bone Marrow Transplantation. Allogeneic bone marrow
transplantation for leukaemia in Europe. Lancet 1988; i: 1979.
9. Speck B. Bortin MM, Champlin R et al. Allogeneic bone marrow
transplantation for chronic myelogenous leukaemia. Lancet 1984;
1:665.
10. Fischer A, Cerf-Bensussan A, Blanche S et al. Allogeneic bone
marrow transplantation for erytrophagocytic lymphohistiocytosis.
J Pediatr 1986; 108:267-70.
11. Ballet JJ, Griscelli C, Coutris C, Milhaud G. Bone marrow
transplantation in osteopetrosis. Lancet 1977; ii:l 137-39.
12. Gratwohl A, Hermans J, Goldman JM, Gahrton G. Bone marrow
transplantation in Europe: Major geographical differences. J. of
Internal Medicine 1993; 233: 333-341.
13. Bortin MM, Rimm AA. Increasing utilization of bone marrow
transplantation. Results of 1985-1987 survey. Transplantation
1989; 48:453.
14. Gratwohl A. Bone marrow transplantation activity in Europe
1990. Report from the European Group for Bone Marrow
transplantation (EBMT). Bone Marrow Transplant 1991; 8:197.
15. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of
allogeneic bone marrow transplantation. Ann Int Med 1992; 116:
505-512.
16. Gratwohl A, Hermans J. Frequency and indication of unrelated
bone marrow transplants in Europe. Bone Marrow Transplant,
1993; 11:1:62-5.
17. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R,
Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J,
McCullough J et al. Analysis of 462 transplantations from
unrelated donors facilitated by the National Marrow Donor
Program. N Engl J Med 1993; 328 (9):593-602.
18. Gratwohl A. Bone marrow transplantation for leukemia in
Europe: Bone Marrow Transplantl991; 7:2:160-161.
19. Gerritsen EJA, Stam ED, Hermans J, Bergh H vd, Haraldsson A,
Tol MJD v, Vossen JM: Follow-up of leucocyte and reticulocyte
count for the prediction of graft rejection after HLA non-identical
BMT in children. Boðin til birtingar.
20. Gerritsen EJA, Stam ED, Hermans J, Bergh H vd, Haraldsson A,
Tol MJD v, Vossen JM: Follow-up of peripheral blood cell counts
for the prediction of lymphoproliferative syndrome in HLA non-
identical bone marrow transplantation in children. Boðin til
birtingar.
21. Van Leeuwen JEM, van Tol MJD, Joosten AM, Schellekens PTA,
Langlois van den Bergh R, Waaijer JLM, Oudeman-Gruber NJ,
van der Weijden-Ragas CPM, Roos MTL, Gerritsen EJA, van den
Berg H, Haraldsson A, Meera Khan P, Vossen JM. Relationship
Between Patterns of Engraftment in Peripheral Blood and Immune
Reconstitution After Allogeneic Bone Marrow Transplantation for
(Severe ) Combined Immunodeficiency. Blood 1994; 84:11:
3936-3947.
22. Vossen JM, van Leeuwen EF, van 'T Veer-Korthof ETh, Slaper-
Cortenbach CM, van den Berg H, Gerritsen EJA, Hermans .1,
Weening RS. De bijdrage van beenmergtransplantatie aan de
behandeling van kinderen met leukemie. Tijdschr
Kindergeneeskd 1988; 56:2.
23. Thomas ED, Buckner CD, Banaji M et al. One hundred patients
with acute leukemia treated by chemotherapy, total body
irradiation and allogeneic marrow transplantation. Blood 1977;
511-33.
24. Bortin MM, Rimm AA. Bone marrow transplantation for acute
myeloblastic leukemia. JAMA 1978;240:1245-52.
25. Thomas ED, Buckner CD, Clift RA et al. Marrow transplantation
for acute nonlymphoblastic leukemia in first remission. N Engl J
Med 1979; 301:697-9.
26. Gale RP, Kersey JH, Bortin MM et al. Bone marrow
transplantation foracute lymphoblastic leukaemia. Lancet 1983;
11:663-7.
27. Zwaan FE, Hermans .1, Barrett AJ et al. Bone marrow
transplantation for acute nonlymphoblastic leukaemia; a survey of
the European Group for Bone Marrow Transplantation (EGBMT).
Br J Haematol 1984;56:645-53.
28. Zwaan FE, Hermans J, Barrett AJ et al. Bone marrow
transplantation for acute lymphoblastic leukaemia; a survey of the
European Group for Bone Marrow Transplantation (EGBMT). Br
J flaematol 1984;58:33-42.
29. Sanders JE, Thomas ED, Buckner CD et al. Marrow
transplantation for children in first remission of acute
nonlymphoblastic leukemia: an update. Blood 1985;66:460-2.
30. Sanders JE, Thomas ED, Buckner CD et al. Marrow
transplantation for children with acute lymphoblastic leukemia in
second remission. Blood 1987;70:324-6.
31. Chessells JM, Rogers DW, Leiper AD et al. Bone marrow
transplantation has a limited role in prolonging second marrow
remission in childhood lymphoblastic leukaemia. Lancet
1986;1:1239-41.
32. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of
Graft-versus-Host disease in human recipients of allogeneic
marrow grafts. N Engl J Med 197;300:1068-73.
33. Gorin NC, Aegerter P for the Working Party on Autologous Bone
Marrow Transplantation of the EBMTG. Autologous bone
marrow transplantation for acute leukaemia in remission: 4th
EBMTG survey. Bone Marrow Transplant 1987;2 suppl.I):320-3.
34. Kersey JH, Weisdorf D, Nesbit ME et al. Comparsion of
autologous and allogeneic bone marrow transplantation for
treatment of high-risk refractory acute lymphoblastic leukemia. N
Engl J Med 1987;317:461-7.
35. Odom LF, August CS, Githens JH et al. Remission of relapsed
leukaemia during a Graft-versus-FIost reaction. Lancet 1978;
11:537-40.
36. Huand S, Terstappen LW. Formation of Flematopoietic Micrto-
Enviornment and Hematopoietic Stem Cells from single Human
Bone Marrow Stem Cell. Nature 1991;360:745-749.
37. Falkenburg JHF, Lim FTH, Oudshoorn M, Haraldsson A, Brand
A, Kanhai HHH, Fibbe WE, van Rood JJ, Willemze R.
Navelstrengbloed ter vervanging van beenmerg voor allogene
transplantatie var hematopoietische stamcellen. Ned Tijdschrift
voorGeneesu 1995; I prentun.
10
LÆKNANEMINN 2.tbl. 1995 48. árg.